Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ezekowitz

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Critical Care Medicine|June 22, 2010
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention TrialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
ESC Heart Failure|March 9, 2022
Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory riskRobert J H Miller, Majid Nabipoor, Erik Youngson, et al.
Current Heart Failure Reports|August 24, 2021
Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment StrategiesPishoy Gouda, Sijia Zheng, Tricia Peters, et al.
CJC Open|September 25, 2023
Right Ventricular Systolic Pressure Trajectory as a Predictor of Hospitalization and Mortality in Patients With Chronic Heart FailureGynter Kotrri, Erik Youngson, Nowell M Fine, et al.
NPJ Digital Medicine|May 18, 2024
Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population levelSunil Vasu Kalmady, Amir Salimi, Weijie Sun, et al.
European Heart Journal|April 14, 2016
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trialRoopinder K Sandhu, Justin Ezekowitz, Ulrika Andersson, et al.
Circulation. Heart Failure|March 24, 2012
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formulaFinlay A McAlister, Justin Ezekowitz, Luigi Tarantini, et al.
CJC Open|March 12, 2020
A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function ClinicsRochelle Bernier, Jessica Ng, Dat T Tran, et al.
European Heart Journal. Cardiovascular Imaging|May 2, 2020
Left atrial remodelling, mid-regional pro-atrial natriuretic peptide, and prognosis across a range of ejection fractions in heart failureBrendan N Putko, Anamaria Savu, Padma Kaul, et al.
Journal of Cardiac Failure|February 8, 2021
Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical TrialsP Elliott Miller, Sean Van Diepen, Thomas S Metkus, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Critical Care Medicine|June 22, 2010
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention TrialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
ESC Heart Failure|March 9, 2022
Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory riskRobert J H Miller, Majid Nabipoor, Erik Youngson, et al.
Current Heart Failure Reports|August 24, 2021
Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment StrategiesPishoy Gouda, Sijia Zheng, Tricia Peters, et al.
CJC Open|September 25, 2023
Right Ventricular Systolic Pressure Trajectory as a Predictor of Hospitalization and Mortality in Patients With Chronic Heart FailureGynter Kotrri, Erik Youngson, Nowell M Fine, et al.
NPJ Digital Medicine|May 18, 2024
Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population levelSunil Vasu Kalmady, Amir Salimi, Weijie Sun, et al.
European Heart Journal|April 14, 2016
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trialRoopinder K Sandhu, Justin Ezekowitz, Ulrika Andersson, et al.
Circulation. Heart Failure|March 24, 2012
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formulaFinlay A McAlister, Justin Ezekowitz, Luigi Tarantini, et al.
CJC Open|March 12, 2020
A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function ClinicsRochelle Bernier, Jessica Ng, Dat T Tran, et al.
European Heart Journal. Cardiovascular Imaging|May 2, 2020
Left atrial remodelling, mid-regional pro-atrial natriuretic peptide, and prognosis across a range of ejection fractions in heart failureBrendan N Putko, Anamaria Savu, Padma Kaul, et al.
Journal of Cardiac Failure|February 8, 2021
Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical TrialsP Elliott Miller, Sean Van Diepen, Thomas S Metkus, et al.
Pageof 11